Now primarily a marketing machine that produces drugs of questionable benefit, the industry uses its wealth and power to co-opt such institutions as the U.S. Congress, the Food and Drug Administration (FDA), academic medical centers, as well as the medical profession. In spite of a lack of innovative drugs and continuously growing prices, the drug companies invest most of their time and money in marketing, legal maneuvers to extend patient rights, and government lobbying to prevent price regulation.